 | • レポートコード：20QY06-04090 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、メチルフェニデート薬のグローバル市場について種類別（タブレット、カプセル）、用途別（子供（6〜17歳）、大人）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・メチルフェニデート薬市場の概要 ・世界の主要地域別メチルフェニデート薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のメチルフェニデート薬市場規模2015-2026：種類別（タブレット、カプセル） ・世界のメチルフェニデート薬市場規模2015-2026：用途別（子供（6〜17歳）、大人） ・メチルフェニデート薬の北米市場規模2015-2020 ・メチルフェニデート薬のヨーロッパ市場規模2015-2020 ・メチルフェニデート薬の中国市場規模2015-2020 ・メチルフェニデート薬の日本市場規模2015-2020 ・メチルフェニデート薬の東南アジア市場規模2015-2020 ・メチルフェニデート薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Janssen Pharmaceuticals、NEOS Therapeutics、Rhodes Pharmaceuticals、Noven Therapeutics、Ironshore Pharmaceuticals、Lannett Company、Novartis、Teva、Tris Pharma、Amneal、Impax Laboratories、Mylan、Trigen Laboratories、Sun Pharmaceutical、Oxford Pharm、Novel Laboratories、Breckenridge Pharmaceutical） ・メチルフェニデート薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・メチルフェニデート薬の市場動向・機会・課題 ・調査の結論 |
Methylphenidate Drug is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Market Analysis and Insights: Global Methylphenidate Drug Market
The global Methylphenidate Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Methylphenidate Drug Scope and Market Size
The global Methylphenidate Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Methylphenidate Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Methylphenidate Drug market is segmented into
Tablet
Capsule
Segment by Application, the Methylphenidate Drug market is segmented into
Children(6-17 years)
Adult
The Methylphenidate Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Methylphenidate Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Methylphenidate Drug Market Share Analysis
Methylphenidate Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Methylphenidate Drug business, the date to enter into the Methylphenidate Drug market, Methylphenidate Drug product introduction, recent developments, etc.
The major vendors covered:
Janssen Pharmaceuticals
NEOS Therapeutics
Rhodes Pharmaceuticals
Noven Therapeutics
Ironshore Pharmaceuticals
Lannett Company
Novartis
Teva
Tris Pharma
Amneal
Impax Laboratories
Mylan
Trigen Laboratories
Sun Pharmaceutical
Oxford Pharm
Novel Laboratories
Breckenridge Pharmaceutical
Table of Contents
1 Methylphenidate Drug Market Overview
1.1 Methylphenidate Drug Product Scope
1.2 Methylphenidate Drug Segment by Type
1.2.1 Global Methylphenidate Drug Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Methylphenidate Drug Segment by Application
1.3.1 Global Methylphenidate Drug Sales Comparison by Application (2020-2026)
1.3.2 Children(6-17 years)
1.3.3 Adult
1.4 Methylphenidate Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Methylphenidate Drug Sales Growth Rate (2015-2026)
1.4.2 Global Methylphenidate Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Methylphenidate Drug Price Trends (2015-2026)
2 Methylphenidate Drug Estimate and Forecast by Region
2.1 Global Methylphenidate Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Methylphenidate Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Methylphenidate Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Methylphenidate Drug Revenue Market Share by Region (2015-2020)
2.3 Global Methylphenidate Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Methylphenidate Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Methylphenidate Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Methylphenidate Drug Estimates and Projections (2015-2026)
2.4.2 Europe Methylphenidate Drug Estimates and Projections (2015-2026)
2.4.3 China Methylphenidate Drug Estimates and Projections (2015-2026)
2.4.4 Japan Methylphenidate Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Methylphenidate Drug Estimates and Projections (2015-2026)
2.4.6 India Methylphenidate Drug Estimates and Projections (2015-2026)
3 Global Methylphenidate Drug Competition Landscape by Players
3.1 Global Top Methylphenidate Drug Players by Sales (2015-2020)
3.2 Global Top Methylphenidate Drug Players by Revenue (2015-2020)
3.3 Global Methylphenidate Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methylphenidate Drug as of 2019)
3.4 Global Methylphenidate Drug Average Price by Company (2015-2020)
3.5 Manufacturers Methylphenidate Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Methylphenidate Drug Players (Opinion Leaders)
4 Global Methylphenidate Drug Market Size by Type
4.1 Global Methylphenidate Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Methylphenidate Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Methylphenidate Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Methylphenidate Drug Price by Type (2014-2020)
4.2 Global Methylphenidate Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Methylphenidate Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Methylphenidate Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Methylphenidate Drug Price Forecast by Type (2021-2026)
5 Global Methylphenidate Drug Market Size by Application
5.1 Global Methylphenidate Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Methylphenidate Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Methylphenidate Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Methylphenidate Drug Price by Application (2015-2020)
5.2 Global Methylphenidate Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Methylphenidate Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Methylphenidate Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Methylphenidate Drug Price Forecast by Application (2021-2026)
3 North America Methylphenidate Drug Market Facts & Figures
3.2 North America Methylphenidate Drug Sales Market Share by Company (2015-2020)
3.3 North America Methylphenidate Drug Sales Market Share by Type (2015-2020)
3.4 North America Methylphenidate Drug Sales Market Share by Application (2015-2020)
4 Europe Methylphenidate Drug Market Facts & Figures
4.2 Europe Methylphenidate Drug Sales Market Share by Company (2015-2020)
4.3 Europe Methylphenidate Drug Sales Market Share by Type (2015-2020)
4.4 Europe Methylphenidate Drug Sales Market Share by Application (2015-2020)
5 China Methylphenidate Drug Market Facts & Figures
5.2 China Methylphenidate Drug Sales Market Share by Company (2015-2020)
5.3 China Methylphenidate Drug Sales Market Share by Type (2015-2020)
5.4 China Methylphenidate Drug Sales Market Share by Application (2015-2020)
6 Japan Methylphenidate Drug Market Facts & Figures
6.2 Japan Methylphenidate Drug Sales Market Share by Company (2015-2020)
6.3 Japan Methylphenidate Drug Sales Market Share by Type (2015-2020)
6.4 Japan Methylphenidate Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Methylphenidate Drug Market Facts & Figures
7.2 Southeast Asia Methylphenidate Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Methylphenidate Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Methylphenidate Drug Sales Market Share by Application (2015-2020)
8 India Methylphenidate Drug Market Facts & Figures
8.2 India Methylphenidate Drug Sales Market Share by Company (2015-2020)
8.3 India Methylphenidate Drug Sales Market Share by Type (2015-2020)
8.4 India Methylphenidate Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Methylphenidate Drug Business
12.1 Janssen Pharmaceuticals
12.1.1 Janssen Pharmaceuticals Methylphenidate Drug Corporation Information
12.1.2 Janssen Pharmaceuticals Methylphenidate Drug Business Overview and Total Revenue
12.1.3 Janssen Pharmaceuticals Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Janssen Pharmaceuticals Methylphenidate Drug Products Offered
12.1.5 Janssen Pharmaceuticals Recent Development
12.2 NEOS Therapeutics
12.2.1 NEOS Therapeutics Methylphenidate Drug Corporation Information
12.2.2 NEOS Therapeutics Methylphenidate Drug Business Overview and Total Revenue
12.2.3 NEOS Therapeutics Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 NEOS Therapeutics Methylphenidate Drug Products Offered
12.2.5 NEOS Therapeutics Recent Development
12.3 Rhodes Pharmaceuticals
12.3.1 Rhodes Pharmaceuticals Methylphenidate Drug Corporation Information
12.3.2 Rhodes Pharmaceuticals Methylphenidate Drug Business Overview and Total Revenue
12.3.3 Rhodes Pharmaceuticals Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Rhodes Pharmaceuticals Methylphenidate Drug Products Offered
12.3.5 Rhodes Pharmaceuticals Recent Development
12.4 Noven Therapeutics
12.4.1 Noven Therapeutics Methylphenidate Drug Corporation Information
12.4.2 Noven Therapeutics Methylphenidate Drug Business Overview and Total Revenue
12.4.3 Noven Therapeutics Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Noven Therapeutics Methylphenidate Drug Products Offered
12.4.5 Noven Therapeutics Recent Development
12.5 Ironshore Pharmaceuticals
12.5.1 Ironshore Pharmaceuticals Methylphenidate Drug Corporation Information
12.5.2 Ironshore Pharmaceuticals Methylphenidate Drug Business Overview and Total Revenue
12.5.3 Ironshore Pharmaceuticals Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Ironshore Pharmaceuticals Methylphenidate Drug Products Offered
12.5.5 Ironshore Pharmaceuticals Recent Development
12.6 Lannett Company
12.6.1 Lannett Company Methylphenidate Drug Corporation Information
12.6.2 Lannett Company Methylphenidate Drug Business Overview and Total Revenue
12.6.3 Lannett Company Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lannett Company Methylphenidate Drug Products Offered
12.6.5 Lannett Company Recent Development
12.7 Novartis
12.7.1 Novartis Methylphenidate Drug Corporation Information
12.7.2 Novartis Methylphenidate Drug Business Overview and Total Revenue
12.7.3 Novartis Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Methylphenidate Drug Products Offered
12.7.5 Novartis Recent Development
12.8 Teva
12.8.1 Teva Methylphenidate Drug Corporation Information
12.8.2 Teva Methylphenidate Drug Business Overview and Total Revenue
12.8.3 Teva Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teva Methylphenidate Drug Products Offered
12.8.5 Teva Recent Development
12.9 Tris Pharma
12.9.1 Tris Pharma Methylphenidate Drug Corporation Information
12.9.2 Tris Pharma Methylphenidate Drug Business Overview and Total Revenue
12.9.3 Tris Pharma Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Tris Pharma Methylphenidate Drug Products Offered
12.9.5 Tris Pharma Recent Development
12.10 Amneal
12.10.1 Amneal Methylphenidate Drug Corporation Information
12.10.2 Amneal Methylphenidate Drug Business Overview and Total Revenue
12.10.3 Amneal Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Amneal Methylphenidate Drug Products Offered
12.10.5 Amneal Recent Development
12.11 Impax Laboratories
12.11.1 Impax Laboratories Methylphenidate Drug Corporation Information
12.11.2 Impax Laboratories Methylphenidate Drug Business Overview and Total Revenue
12.11.3 Impax Laboratories Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Impax Laboratories Methylphenidate Drug Products Offered
12.11.5 Impax Laboratories Recent Development
12.12 Mylan
12.12.1 Mylan Methylphenidate Drug Corporation Information
12.12.2 Mylan Methylphenidate Drug Business Overview and Total Revenue
12.12.3 Mylan Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Mylan Methylphenidate Drug Products Offered
12.12.5 Mylan Recent Development
12.13 Trigen Laboratories
12.13.1 Trigen Laboratories Methylphenidate Drug Corporation Information
12.13.2 Trigen Laboratories Methylphenidate Drug Business Overview and Total Revenue
12.13.3 Trigen Laboratories Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Trigen Laboratories Methylphenidate Drug Products Offered
12.13.5 Trigen Laboratories Recent Development
12.14 Sun Pharmaceutical
12.14.1 Sun Pharmaceutical Methylphenidate Drug Corporation Information
12.14.2 Sun Pharmaceutical Methylphenidate Drug Business Overview and Total Revenue
12.14.3 Sun Pharmaceutical Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Sun Pharmaceutical Methylphenidate Drug Products Offered
12.14.5 Sun Pharmaceutical Recent Development
12.15 Oxford Pharm
12.15.1 Oxford Pharm Methylphenidate Drug Corporation Information
12.15.2 Oxford Pharm Methylphenidate Drug Business Overview and Total Revenue
12.15.3 Oxford Pharm Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Oxford Pharm Methylphenidate Drug Products Offered
12.15.5 Oxford Pharm Recent Development
12.16 Novel Laboratories
12.16.1 Novel Laboratories Methylphenidate Drug Corporation Information
12.16.2 Novel Laboratories Methylphenidate Drug Business Overview and Total Revenue
12.16.3 Novel Laboratories Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Novel Laboratories Methylphenidate Drug Products Offered
12.16.5 Novel Laboratories Recent Development
12.17 Breckenridge Pharmaceutical
12.17.1 Breckenridge Pharmaceutical Methylphenidate Drug Corporation Information
12.17.2 Breckenridge Pharmaceutical Methylphenidate Drug Business Overview and Total Revenue
12.17.3 Breckenridge Pharmaceutical Methylphenidate Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Breckenridge Pharmaceutical Methylphenidate Drug Products Offered
12.17.5 Breckenridge Pharmaceutical Recent Development
13 Methylphenidate Drug Manufacturing Cost Analysis
13.1 Methylphenidate Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Methylphenidate Drug
13.4 Methylphenidate Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Methylphenidate Drug Distributors List
14.3 Methylphenidate Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Methylphenidate Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Methylphenidate Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Methylphenidate Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Methylphenidate Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Methylphenidate Drug Sales Market Share by Region (2015-2020)
Table 6. Global Methylphenidate Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Methylphenidate Drug Revenue Share by Region (2015-2020)
Table 8. Global Methylphenidate Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Methylphenidate Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Methylphenidate Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Methylphenidate Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Methylphenidate Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Methylphenidate Drug Sales Share by Company (2015-2020)
Table 14. Global Methylphenidate Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Methylphenidate Drug Revenue Share by Company (2015-2020)
Table 16. Global Methylphenidate Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methylphenidate Drug as of 2019)
Table 17. Global Methylphenidate Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Methylphenidate Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Methylphenidate Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Methylphenidate Drug Players
Table 22. Global Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Methylphenidate Drug Sales Share by Type (2015-2020)
Table 24. Global Methylphenidate Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Methylphenidate Drug Price (K MT) by Type (2015-2020)
Table 26. Global Methylphenidate Drug Sales Share by Type (2021-2026)
Table 27. Global Methylphenidate Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Methylphenidate Drug Revenue Share by Type (2021-2026)
Table 29. Global Methylphenidate Drug Price (K MT) by Type (2021-2026)
Table 30. Global Methylphenidate Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Methylphenidate Drug Sales Share by Application (2015-2020)
Table 32. Global Methylphenidate Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Methylphenidate Drug Price (K MT) by Application (2015-2020)
Table 34. Global Methylphenidate Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Methylphenidate Drug Sales Share by Application (2021-2026)
Table 36. Global Methylphenidate Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Methylphenidate Drug Revenue Share by Application (2021-2026)
Table 38. Global Methylphenidate Drug Price (K MT) by Application (2021-2026)
Table 39. United States Methylphenidate Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Methylphenidate Drug Sales Market Share by Company (2015-2020)
Table 41. United States Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 43. United States Methylphenidate Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Methylphenidate Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Methylphenidate Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Methylphenidate Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Methylphenidate Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 51. China Methylphenidate Drug Sales (K MT) by Company (2015-2020)
Table 52. China Methylphenidate Drug Sales Market Share by Company (2015-2020)
Table 53. China Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 54. China Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 55. China Methylphenidate Drug Sales (K MT) by Application (2015-2020)
Table 56. China Methylphenidate Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Methylphenidate Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Methylphenidate Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Methylphenidate Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Methylphenidate Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Methylphenidate Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Methylphenidate Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Methylphenidate Drug Sales Market Share by Application (2015-2020)
Table 69. India Methylphenidate Drug Sales (K MT) by Company (2015-2020)
Table 70. India Methylphenidate Drug Sales Market Share by Company (2015-2020)
Table 71. India Methylphenidate Drug Sales (K MT) by Type (2015-2020)
Table 72. India Methylphenidate Drug Sales Market Share by Type (2015-2020)
Table 73. India Methylphenidate Drug Sales (K MT) by Application (2015-2020)
Table 74. India Methylphenidate Drug Sales Market Share by Application (2015-2020)
Table 75. Janssen Pharmaceuticals Corporation Information
Table 76. Janssen Pharmaceuticals Description and Business Overview
Table 77. Janssen Pharmaceuticals Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Janssen Pharmaceuticals Methylphenidate Drug Product
Table 79. Janssen Pharmaceuticals Recent Development
Table 80. NEOS Therapeutics Corporation Information
Table 81. NEOS Therapeutics Description and Business Overview
Table 82. NEOS Therapeutics Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. NEOS Therapeutics Methylphenidate Drug Product
Table 84. NEOS Therapeutics Recent Development
Table 85. Rhodes Pharmaceuticals Corporation Information
Table 86. Rhodes Pharmaceuticals Description and Business Overview
Table 87. Rhodes Pharmaceuticals Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Rhodes Pharmaceuticals Methylphenidate Drug Product
Table 89. Rhodes Pharmaceuticals Recent Development
Table 90. Noven Therapeutics Corporation Information
Table 91. Noven Therapeutics Description and Business Overview
Table 92. Noven Therapeutics Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Noven Therapeutics Methylphenidate Drug Product
Table 94. Noven Therapeutics Recent Development
Table 95. Ironshore Pharmaceuticals Corporation Information
Table 96. Ironshore Pharmaceuticals Description and Business Overview
Table 97. Ironshore Pharmaceuticals Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Ironshore Pharmaceuticals Methylphenidate Drug Product
Table 99. Ironshore Pharmaceuticals Recent Development
Table 100. Lannett Company Corporation Information
Table 101. Lannett Company Description and Business Overview
Table 102. Lannett Company Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Lannett Company Methylphenidate Drug Product
Table 104. Lannett Company Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Novartis Methylphenidate Drug Product
Table 109. Novartis Recent Development
Table 110. Teva Corporation Information
Table 111. Teva Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Teva Description and Business Overview
Table 113. Teva Methylphenidate Drug Product
Table 114. Teva Recent Development
Table 115. Tris Pharma Corporation Information
Table 116. Tris Pharma Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Tris Pharma Description and Business Overview
Table 118. Tris Pharma Methylphenidate Drug Product
Table 119. Tris Pharma Recent Development
Table 120. Amneal Corporation Information
Table 121. Amneal Description and Business Overview
Table 122. Amneal Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Amneal Methylphenidate Drug Product
Table 124. Amneal Recent Development
Table 125. Impax Laboratories Corporation Information
Table 126. Impax Laboratories Description and Business Overview
Table 127. Impax Laboratories Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Impax Laboratories Methylphenidate Drug Product
Table 129. Impax Laboratories Recent Development
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Mylan Methylphenidate Drug Product
Table 134. Mylan Recent Development
Table 135. Trigen Laboratories Corporation Information
Table 136. Trigen Laboratories Description and Business Overview
Table 137. Trigen Laboratories Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Trigen Laboratories Methylphenidate Drug Product
Table 139. Trigen Laboratories Recent Development
Table 140. Sun Pharmaceutical Corporation Information
Table 141. Sun Pharmaceutical Description and Business Overview
Table 142. Sun Pharmaceutical Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Sun Pharmaceutical Methylphenidate Drug Product
Table 144. Sun Pharmaceutical Recent Development
Table 145. Oxford Pharm Corporation Information
Table 146. Oxford Pharm Description and Business Overview
Table 147. Oxford Pharm Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Oxford Pharm Methylphenidate Drug Product
Table 149. Oxford Pharm Recent Development
Table 150. Novel Laboratories Corporation Information
Table 151. Novel Laboratories Description and Business Overview
Table 152. Novel Laboratories Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Novel Laboratories Methylphenidate Drug Product
Table 154. Novel Laboratories Recent Development
Table 155. Breckenridge Pharmaceutical Corporation Information
Table 156. Breckenridge Pharmaceutical Description and Business Overview
Table 157. Breckenridge Pharmaceutical Methylphenidate Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Breckenridge Pharmaceutical Methylphenidate Drug Product
Table 159. Breckenridge Pharmaceutical Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Methylphenidate Drug Distributors List
Table 163. Methylphenidate Drug Customers List
Table 164. Market Key Trends
Table 165. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 166. Key Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Methylphenidate Drug Product Picture
Figure 2. Global Methylphenidate Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Methylphenidate Drug Market Share by Application in 2020 & 2026
Figure 6. Children(6-17 years) Examples
Figure 7. Adult Examples
Figure 8. Global Methylphenidate Drug Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Methylphenidate Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Methylphenidate Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Methylphenidate Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Methylphenidate Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Methylphenidate Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Methylphenidate Drug Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Methylphenidate Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Methylphenidate Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Methylphenidate Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Methylphenidate Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Methylphenidate Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Methylphenidate Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Methylphenidate Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Methylphenidate Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Methylphenidate Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Methylphenidate Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Methylphenidate Drug Players Market Share by Revenue in Methylphenidate Drug 2015 & 2019
Figure 26. Methylphenidate Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Methylphenidate Drug Revenue Share by Type (2015-2020)
Figure 28. Global Methylphenidate Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Methylphenidate Drug Revenue Share by Application (2015-2020)
Figure 30. Global Methylphenidate Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Methylphenidate Drug Sales Market Share by Type in 2019
Figure 32. United States Methylphenidate Drug Sales Market Share by Type in 2019
Figure 33. Europe Methylphenidate Drug Sales Market Share by Company in 2019
Figure 34. Europe Methylphenidate Drug Sales Market Share by Type in 2019
Figure 35. Europe Methylphenidate Drug Sales Market Share by Application in 2019
Figure 36. China Methylphenidate Drug Sales Market Share by Company in 2019
Figure 37. China Methylphenidate Drug Sales Market Share by Type in 2019
Figure 38. China Methylphenidate Drug Sales Market Share by Application in 2019
Figure 39. Japan Methylphenidate Drug Sales Market Share by Company in 2019
Figure 40. Japan Methylphenidate Drug Sales Market Share by Type in 2019
Figure 41. Japan Methylphenidate Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Methylphenidate Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Methylphenidate Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Methylphenidate Drug Sales Market Share by Application in 2019
Figure 45. India Methylphenidate Drug Sales Market Share by Company in 2019
Figure 46. India Methylphenidate Drug Sales Market Share by Type in 2019
Figure 47. India Methylphenidate Drug Sales Market Share by Application in 2019
Figure 48. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. NEOS Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Rhodes Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Noven Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ironshore Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Lannett Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Tris Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Amneal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Impax Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Trigen Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Oxford Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Novel Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Breckenridge Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Methylphenidate Drug
Figure 67. Manufacturing Process Analysis of Methylphenidate Drug
Figure 68. Methylphenidate Drug Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
メチルフェニデートの世界市場レポート2020 Market Analysis and Insights: Global Methylphenidate Market The global Methylphenidate market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Methylphenidate Scope and Market Size The global Methylphenidate mark…- メチルフェニデートの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Methylphenidate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Methylphenidate market report…
- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…